Skip to the reference

Reference desk / Entry

Semaglutide

Also listed as: Wegovy

Read the scope first. Then use the note and questions to examine what the evidence can answer.

Scoped product status
Approved product
Evidence label
Randomized evidence
Status as of

Reference fields

References for these fields are listed together in Sources.

Product and use scope
Wegovy injection: weight management in eligible adults.
Route context
This entry covers subcutaneous Wegovy injection.
Mechanism
Activates the GLP-1 receptor.
Evidence
Randomized trials.
Limitations
Check other products separately.
Safety
Severe or persistent gastrointestinal symptoms: contact a clinician.

A question worth making clear

Give a discussion a common starting point by writing the comparison as a complete question. Name what is being considered, the alternative it is being compared with, and the result that would distinguish them. Invite another reader to describe that same question in their own words. If the descriptions differ, settle the difference before debating a result. A report might answer one comparison accurately while leaving a nearby comparison open. Making the alternatives explicit helps everyone see which answer is needed and whether the cited evidence supplies it.

  1. What are the two alternatives in the question we want this report to answer?
  2. Would another reader describe the same comparison from the wording we have chosen?
  3. Which part of our comparison is addressed directly, and which part remains open?

Sources

Each date below belongs to the supplied source record. The references support the entry as a group.